Cargando…
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale
INTRODUCTION: For many people with type 1 diabetes who struggle to achieve glycaemic control with multiple daily injections of insulin (MDI) plus self-monitoring of blood glucose, MDI plus intermittently scanned continuous glucose monitoring (IS-CGM) or real-time continuous glucose monitoring (RT-CG...
Autores principales: | de Portu, Simona, Vorrink, Linda, Re, Roseline, Shin, John, Castaneda, Javier, Habteab, Aklilu, Cohen, Ohad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811581/ https://www.ncbi.nlm.nih.gov/pubmed/35110310 http://dx.doi.org/10.1136/bmjopen-2021-050635 |
Ejemplares similares
-
Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized Trial
por: Habteab, Aklilu, et al.
Publicado: (2020) -
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
por: McAuley, Sybil A, et al.
Publicado: (2018) -
Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol
por: de Bock, Martin, et al.
Publicado: (2018) -
Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol
por: Jancev, Milena, et al.
Publicado: (2023) -
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
por: Waldron-Lynch, Frank, et al.
Publicado: (2014)